Back to Companies
LENZ Therapeutics, Inc.
LENZNasdaqCIK: 0001815776
Over the 20 most recent insider filings, LENZ Therapeutics, Inc. (LENZ) has seen activity from 12 distinct insiders — 3 buying and 2 selling. The activity is heavily weighted toward selling: $365.6K bought versus $40.5M sold, net sales of $40.1M. Versant Venture Capital VI, L.P. is the most active by dollar volume, and the single largest transaction was $10.4M by Versant Venture Capital VI, L.P.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$51.7M
Purchases
$365.6K
Sales
$40.5M
Unique Insiders
12
Recent Insider Trades
20 loaded
| Jun 15 | LENZ LENZ Therapeutics, Inc. | Scheiner Zachary | Director | Award | $146.5K |
| Jun 15 | LENZ LENZ Therapeutics, Inc. | MCCOLLUM JAMES W | Director | Award | $146.5K |
| Jun 15 | LENZ LENZ Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $146.5K |
| Jun 15 | LENZ LENZ Therapeutics, Inc. | Guerard Frederic | Director | Award | $146.5K |
| Jun 15 | LENZ LENZ Therapeutics, Inc. | Thunen Shelley B | Director | Award | $146.5K |
| Jun 15 | LENZ LENZ Therapeutics, Inc. | George Jeffrey P. | Director | Award | $146.5K |
| Jun 15 | LENZ LENZ Therapeutics, Inc. | Drapkin Kimberlee C | Director | Award | $146.5K |
| Mar 30 | LENZ LENZ Therapeutics, Inc. | George Jeffrey P. | Director | Buy | $49.9K |
| Mar 30 | LENZ LENZ Therapeutics, Inc. | Schimmelpennink Evert B. | President, CEO and Secretary, Director | Buy | $251.4K |
| Mar 30 | LENZ LENZ Therapeutics, Inc. | Chevallard Daniel R. | Chief Financial Officer | Buy | $64.3K |
| Jan 6 | LENZ LENZ Therapeutics, Inc. | Chevallard Daniel R. | Chief Financial Officer | Award | $1.3M |
| Jan 6 | LENZ LENZ Therapeutics, Inc. | Odrich Marc | Chief Medical Officer | Award | $1.3M |
| Jan 6 | LENZ LENZ Therapeutics, Inc. | Schimmelpennink Evert B. | President, CEO and Secretary, Director | Award | $5.7M |
| Jan 6 | LENZ LENZ Therapeutics, Inc. | Olsson Shawn | Chief Commercial Officer | Award | $1.3M |
| Nov 19 | LENZ LENZ Therapeutics, Inc. | Olsson Shawn | Chief Commercial Officer | Sell | $261.0K |
| Oct 2 | LENZ LENZ Therapeutics, Inc. | Versant Venture Capital VI, L.P. | Insider | Sell | $10.4M |
| Sep 22 | LENZ LENZ Therapeutics, Inc. | Versant Venture Capital VI, L.P. | Insider | Sell | $5.7M |
| Aug 26 | LENZ LENZ Therapeutics, Inc. | Versant Venture Capital VI, L.P. | Insider | Sell | $7.4M |
| Aug 19 | LENZ LENZ Therapeutics, Inc. | Versant Venture Capital VI, L.P. | Insider | Sell | $10.3M |
| Jul 14 | LENZ LENZ Therapeutics, Inc. | Versant Venture Capital VI, L.P. | Insider | Sell | $6.5M |
20 filings